Novavax says U.S. FDA clears COVID vaccine doses for release

(Reuters) – Vaccine maker Novavax on Tuesday mentioned that the U.S. Meals and Drug Administration had cleared a number of its COVID vaccine for launch in the US, and it plans to ship doses to be distributed by the U.S. authorities within the coming days.

The FDA approved the vaccine final week, however the manufactured doses had been nonetheless awaiting high quality testing earlier than they might be launched.

Advisers to the U.S. Facilities for Illness Management and Prevention (CDC) on Tuesday voted unanimously to advocate use of the vaccine, and rollout of the pictures can start as soon as the company’s director indicators off on that advice.

(Reporting by Michael Erman; Enhancing by Mark Porter)